Serotonin in Early Onset, Male Alcoholics with Violent Behaviour

References

• Cloninger R, Bohman M, Sigvardsson S. Inheritance of alcohol abuse: Cross-fostering analysis of adopted men. Arch Gen Psychiatry 1981; 38: 861–8
   PubMed Web of Science ®Google Scholar
• Cloninger C R., Sigvardsson S, von Knorring A-L, Bohman M. The Swedish studies of the adopted children of alcoholics: A reply to Littrell. J Stud Alcohol 1988; 49: 500–9
   Google Scholar
• Gilligan S B., Reich T, Cloninger C R. Etiological heterogeneity in alcoholism. Genet Epidemiol 1987; 4: 395–414
   PubMed Web of Science ®Google Scholar
• Linnoila M. Neurotransmitters and alcoholism: Methodological issues. Adv Alcohol Subst Abuse 1989; 1: 17–24
   Google Scholar
• Li T-K, Lumeng L, McBride W J., Murphy J M., Froehlich J C., Morzorati S. Pharmacology of alcohol preference in rodents. Adv Alcohol Subst Abuse 1989; 1: 73–86
   Google Scholar
• Murphy J M., Waller M B., Gatto G J., McBride W J., Lumeng L, Li T.-K. Monoamine uptake inhibitors attenuate ethanol intake in alcohol-preferring (P) rats. Alcohol 1985; 2: 349–52
   PubMed Web of Science ®Google Scholar
• Waller M B., Murphy J M., McBride W J., Lumeng L, Li T.-K. Studies on the reinforcing properties of ethanol in alcohol-preferring (P) rats. Alcohol Clin Exp Res 1985; 9: 207
   Web of Science ®Google Scholar
• Naranjo C A., Sellers E M., Roach C A., Woodley D V., Sanchez-Craig M, Sykora K. Zimelidine-induced variations in alcohol intake by nondepressed heavy drinkers. Clin Pharmacol Ther 1984; 35: 374–81
   PubMed Web of Science ®Google Scholar
• Naranjo C A., Sellers E M., Sullivan J T., Woodley D V., Kadlec K, Sykora K. The serotonin uptake inhibitor citalopram alternates ethanol intake. Clin Pharmacol Ther 1987; 41: 266–74
   PubMed Web of Science ®Google Scholar
• Linnoila M, Virkkunen M, Scheinin M, Nuutila A, Rimon R, Goodwin F. Low cerebrospinal fluid 5-hydroxyindoleacetic acid concentration differentiates impulsive from nonimpulsive violent behavior. Life Sci 1983; 33: 2609–14
   PubMed Web of Science ®Google Scholar
• Linnoila M, De Jong J, Virkkunen M. Family history of alcoholism in violent offenders and impulsive fire setters. Arch Gen Psychiatry 1989; 46: 613–6
   PubMed Web of Science ®Google Scholar
• Virkkunen M, Nuutila A, Goodwin F K., Linnoila M. Cerebrospinal fluid monoamine metabolite levels in male arsonists. Arch Gen Psychiatry 1987; 44: 241–7
   PubMed Web of Science ®Google Scholar
• Virkkunen M, De Jong J, Goodwin F K., Linnoila M. Relationship of psychobiological variables to recidivism in violent offenders and impulsive fire setters. A follow-up study. Arch Gen Psychiatry 1989; 46: 600–3
   PubMed Web of Science ®Google Scholar
• Diagnostic and statistical manual of mental disorders (DSM-III-R). American Psychiatric Association, Washington, DC 1987
   Google Scholar
• Cloninger C R. A systematic method for clinical description and classification of personality variants. Arch Gen Psychiatry 1987; 44: 573–88
   PubMed Web of Science ®Google Scholar
• Cloninger C R., Sigvardsson S, Bohman M. Childhood personality predicts alcohol abuse in young adults. Alcohol Clin Exp Res 1988; 12: 494–505
   PubMed Web of Science ®Google Scholar
• Virkkunen M. Insulin secretion during the glucose tolerance test in antisocial personality. Br J Psychiatry 1983; 142: 598–604
   PubMed Web of Science ®Google Scholar
• Von Knorring L, von Knorring A-L, Smigan L, Lindberg U, Edholm M. Personality traits in subtypes of alcoholics. J Stud Alcohol 1987; 48: 523–7
   PubMed Web of Science ®Google Scholar
• Kalant H. Tolerance, learning, and neurochemical adaptation. Can J Physiol Pharmacol 1985; 63: 1485–94
   PubMed Web of Science ®Google Scholar
• Khanna J M., Kalent H, Le A D., LeBlanc A E. Role of serotonin (5-HT) in drug tolerance and general adaptation. Acta Psychiatr Scand (suppl) 1980; 286: 161–70
   Google Scholar
• Le A D., Khanna J M., Kalant H, LeBlanc A E. Effect of modification of brain serotonin (5-HT), norepinephrine (NE) and dopamine (DA) on ethanol tolerance. Psychopharmacology (Berlin) 1981; 75: 231–5
   PubMed Web of Science ®Google Scholar
• Agren H, Mefford I N., Rudorfer M V., Linnoila M, Potter W Z. Interacting neurotransmitter systems. A non-experimental approach to the 5-HIAA-HVA correlation in human CSF. J Psychiatr Res 1986; 20: 175–93
   PubMed Web of Science ®Google Scholar
• Linnoila M, Virkkunen M, Roy A, Potter W Z. Monoamines, glucose metabolism and impulse control. Violence and suicidality. Perspectives in clinical and psychobiological research, H Van Praag, R Plutchik, A Apter. Brunner-Mazel, New York 1990; 218–41
   Google Scholar
• Gottfries C G., Oreland L, Wiberg A, Winblad B. Lowered monoamine oxidase activity in brains from alcoholic suicides. J Neurochem 1975; 25: 667–73
   PubMed Web of Science ®Google Scholar
• Oreland L, Gottfries C G., Kiianmaa K, Wiberg A, Winblad B. The activity of monoamine oxidase-A and-B in brains from chronic alcoholics. J Neural Transm 1983; 56: 73–83
   PubMed Web of Science ®Google Scholar
• Oreland L. Why do alcoholics have low platelet MAO activity?. Biological and/or genetic factors in alcoholism, E Shaskan, R E. Meyer. US Government Printing Office, Washington, DC 1983; 9: 119–30, Res Monogr
   Google Scholar
• Oreland L, von Knorring L, von Knorring A-L, Bohman M. Studies on the connection between alcoholism and low platelet monoamine oxidase activity. Progress in alcohol research, S Parvez, E Burns, Y Burrow, H Parvez. VNU Science Press, Utrecht 1985; 83–117
   Google Scholar
• Von Knorring A-L, Bohman M, von Knorring L, Oreland L. Platelet MAO activity as a biological marker in subgroups of alcoholism. Acta Psychiatr Scand 1985; 72: 51–8
   PubMed Web of Science ®Google Scholar
• Lidberg L, Modin I, Oreland L, Tuck J R., Gillner A. Platelet MAO oxidase activity and psychopathy. Psychiatr Res 1985; 16: 339–43
   PubMed Web of Science ®Google Scholar
• Cloninger C R., von Knorring L, Oreland L. Pentametric distribution of platelet monoamine oxidase activity. Psychiatr Res 1985; 15: 133–43
   PubMed Web of Science ®Google Scholar
• Von Knorring L, Oreland L, Winblad B. Personality traits related to monoamine oxidase (MAO) in platelets. Psychiatr Res 1984; 12: 11–26
   PubMed Web of Science ®Google Scholar
• Winblad B, Gottfries C G., Oreland L, Wiberg A. Monoamine oxidase in platelets and brains in non-psychiatric and nonneurological geriatric patients. Med Biol 1979; 57: 129–32
   PubMedGoogle Scholar
• Young W F., Jr, Laws E R., Jr, Sharbrough F W., Weinshilboum R M. Human monoamine oxidase. Lack of brain and platelet correlation. Arch Gen Psychiatry 1986; 43: 604–9
   PubMed Web of Science ®Google Scholar
• Oreland L, Arai Y, Stenström A. Age, neuropsychiatric diseases and brain monoamine oxidase. Monoamine oxidase and disease, K F. Tipton, P Dostert, M Strolin Benedetti. Academic Press, New York 1984; 291–300
   Google Scholar
• Sakurai E, Niwa H, Oreland L. Relation between serotonin uptake rates, serotonin concentrations and monoamine oxidase activities in various regions of rat brain. Third Amine Oxidases International Workshop. Pharmacol Res Commun (suppl) 1988; 4: 97–9
   Google Scholar
• Soubrie H P. Reconciling the role of central serotonin neurons in human and animal behaviour. Behav Brain Sci 1986; 9: 319–64
   Web of Science ®Google Scholar
• Fernström J D., Wurtman R J. Brain serotonin content: Increase following ingestion of carbohydrate diet. Science 1971; 174: 1023–5
   PubMed Web of Science ®Google Scholar
• Fernström J D., Wurtman R J. Brain serotonin content: Physiological regulation by plasma neutral amino acids. Science 1972; 178: 414–6
   PubMed Web of Science ®Google Scholar
• Wurtman J J., Wurtman R J., Marks S, Tsay R, Gilbert M, Crowdon J. D-Fenfluramine selectively suppresses carbohydrate snacking in obese subjects. Int J Eating Disord 1985; 4: 89–99
   PubMed Web of Science ®Google Scholar
• Spring B, Chiado J, Harden M, Bourgeois M J., Mason J D., Lutherer L. Psychobiological effects of carbohydrates. J Clin Psychiatry 1989; 50: 27–33
   PubMed Web of Science ®Google Scholar
• Fernström J D. Tryptophan, serotonin and carbohydrate appetite: Will the real carbohydrate craver please stand up. J Nutr 1988; 118: 1417–9
   PubMed Web of Science ®Google Scholar
• Badaway A.-B. Alcohol as a psychopharmacological agent. Alcohol and aggression, P F. Brain. Groom Helm, London 1986; 55–83
   Google Scholar
• Badaway A A-B, Morgan C J., Lane J, Dhaliwal K, Bradley D M. Liver tryptophan pyrrolase. A major determinant of the lower brain 5-hydroxytryptamine concentration in alcohol-preferring C57BL mice. Biochem J 1989; 264: 597–9
   PubMed Web of Science ®Google Scholar
• Roy A, Virkkunen M, Guthrie S, Linnoila M. Indices of serotonin and glucose metabolism in violent offenders, arsonists and alcoholics. Psychobiology of suicidal behavior, J J. Mann, M Stanley. Ann N Y Acad Sci. 1986; 487: 202–20
   Google Scholar
• Buydens-Branchey L, Branchey M H., Noumair D, Lieber C S. Age of alcoholism onset. II. Relationship to susceptability to serotonin precursor availability. Arch Gen Psychiatry 1989; 46: 231–6
   PubMed Web of Science ®Google Scholar
• Buydens-Branchey L, Branchey M H., Noumair D. Age of alcoholism onset. I. Relationship to psychopathology. Arch Gen Psychiatry 1989; 46: 225–30
   PubMed Web of Science ®Google Scholar
• Branchey L, Branchey M, Zucker D, Shaw S, Lieber C S. Association between low plasma tryptophan and blackouts in male alcoholic patients. Alcohol 1985; 9: 393–5
   Web of Science ®Google Scholar
• Virkkunen M, Närvänen S. Plasma insulin, tryptophan and serotonin levels during the glucose tolerance test among habitually violent and impulsive offenders. Neuropsychobiology 1987; 17: 19–23
   PubMed Web of Science ®Google Scholar
• Garattini S, Buczko W, Jori A, Samanin R. The mechanism of action of fenfluramine. Postgrad Med J 1975; 51(suppl 1)27–35
   PubMed Web of Science ®Google Scholar
• Quattrone A, Tedeschi G, Aguglia U, Scopacasa F, DiRenzo G F., Anunziato L. Prolactin secretion in man. A useful tool to evaluate the activity of drugs on central 5-hydroxytryptaminergic neurons. Studies with fenfluramine. Br J Clin Pharmacol 1983; 16: 471–5
   PubMed Web of Science ®Google Scholar
• Fuller R W., Snoddy H D., Hemrick S K. Effects of fenfluramine and norfenfluramine on brain serotonin metabolism in rats (40021). Proc Soc Exp Biol Med 1978; 157: 202–5
   PubMed Web of Science ®Google Scholar
• Lewis D A., Sherman B M. Serotonergic stimulation of adrenocorticotrophin secretion in man. J Clin Endocrinol Metab 1984; 58: 458–62
   PubMed Web of Science ®Google Scholar
• Murphy D L., Mueller E A., Garrick N A., Aulakh C S. Use of serotonergic agents in the clinical assessment of central serotonin function. J Clin Psychiatry 1986; 47(suppl)9–13
   PubMedGoogle Scholar
• Fishbein D H., Lozovsky D, Jaffe J H. Impulsivity, aggression, and neuroendocrine responses to serotonergic stimulation in substance abusers. Biol Psychiatry 1989; 25: 1049–66
   PubMed Web of Science ®Google Scholar
• Coccaro E F., Siever L J., Klar H M., et al. Serotonergic studies in patients with affective and personality disorders: Correlates with suicidal and impulsive aggressive behavior. Arch Gen Psychiatry 1989; 46: 587–99
   PubMed Web of Science ®Google Scholar